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I N T R O D U C T I O N
Extracellular ATP has been suggested to serve as a neurotransmitter, neuromodulator, cytotoxin, and mitogen in various systems (see Bobbin 1996; Bobbin et al. 1998; Burnstock 1990; Housley 1997) . Ionotropic (P2X) receptors for ATP are found on cells throughout the cochlea (Housley et al. 1999; Xiang et al. 1999) . The response to ATP differs greatly among cell types in terms of the biophysics and pharmacology. For instance, the current response to ATP shows very little desensitization in outer hair cells (OHCs) Housley et al. 1992; Kujawa et al. 1994; Nakagawa et al. 1990 ) whereas desensitization is relatively fast in Deiters' cells, pillar cells, and inner hair cells (Ashmore and Ohmori 1990; Skellett et al. 1997; Sugasawa et al. 1996a,b) . In addition, the application of the ATP receptor antagonists also shows a difference in the blockade of ATP-gated current among the cell types Skellett et al. 1997) . Such variations in phenotype between cells may partly be caused by differences in the subunit composition of the receptors. Furthermore, alternate splicing of individual subunit mRNA may produce variants with different properties that contribute to the biophysical differences seen in vivo (e.g., Partin et al. 1996) .
Seven subunits of the P2X receptors (i.e., P2X 1 , P2X 2 , P2X 3 , P2X 4 , P2X 5 , P2X 6 , and P2X 7 ) have been isolated . To date P2X 2 is the only ATP receptor type that has been identified in the inner ear (Brandle et al. 1997; Housley et al. 1995; Parker et al. 1998; Troyanovskaya and Wackym 1998) . In addition, several splice variants of P2X 2 have been identified in different tissues (Brandle et al. 1997; Housley et al. 1995; Koshimizu et al. 1998; Parker et al. 1999; Simon et al. 1997; Troyanovskaya and Wackym 1998) . Heterologous expression of the wildtype P2X 2 (or P2X 2-1 or P2X 2a ) receptor isoform and the P2X 2-2 (or P2X 2b ) splice variant obtained from rats resulted in the formation of functional homomeric receptors with different characteristics (Brandle et al. 1997; Koshimizu et al. 1998; Simon et al. 1997) . Parker et al. (1998) recently sequenced three splice variants of the P2X 2 receptor from a guinea pig organ of Corti cDNA library: P2X 2-1 , P2X 2-2 , and P2X 2-3 (or P2X 2? ). The sequences of the P2X 2-1 and P2X 2-2 variants are similar to those previously isolated from the rat. The P2X 2-3 has not been characterized functionally and is unusual in that a significantly long sequence of amino acids is included in the putative extracellular domain. Therefore the purpose of this study was to examine whether these three variants, especially the P2X 2-3 , could be expressed as functional homomeric receptors. For this purpose the three splice variants were individually and transiently expressed in human embryonic kidney cells (HEK293). The
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properties of the three P2X 2 receptor variants were characterized using the whole cell voltage-clamp technique.
M E T H O D S

Construction of recombinant plasmids
The recombinant plasmids pEGFP-N1-P2X 2-1 , pEGFP-N1-P2X 2-2 , and pEGFP-N1-P2X 2-3 , which carry the entire protein coding sequence of the guinea pig P2X2 splice variants, were constructed as follows. Previously described cDNA clones (Parker et al. 1998 ) isolated from a guinea pig organ of Corti library (Wilcox and Fex 1992) were digested with Bam HI and Hin dIII and subcloned into a eukaryotic expression vector (Enhanced Green Fluorescent Protein, pEGFP-N1, Clontech, Palo Alto, CA). The insertion of the cDNA eliminated the translation of the green fluorescent protein encoded downstream of the cloning site in pEGFP-N1 (data not shown). Transfection quality DNA was obtained by Qiagen Maxiprep column purification from One Shot competent cells (Inv␣F, Invitrogen, Carlsbad, CA) bearing the respective expression plasmid. Verification of each variant inserted into the expression vector was confirmed by restriction mapping and by sequencing each variant at the 5Ј and 3Ј ends.
Functional expression in HEK293 cells
Cells were maintained in minimum essential medium (MEM) supplemented with 10% fetal calf serum (FCS) at 37°C in 5% CO 2 . Approximately 10 3 cells were seeded onto sterile coverslips within 35-mm culture dishes before transfection with the appropriate cDNA expression plasmid and the native pEGFP vector as a fluorescent reporter. Twenty-four hours after plating, cells were transfected using Lipofectin (Life Technologies, Gaithersburg, MD). For transfection, 1 g of pEGFP-N1 and 1 g of cDNA construct were mixed with 97 L of OptiMEM (serum free; Life Technologies, Gaithersburg, MD) and incubated at room temperature for 30 min. Ten L of Lipofectin and 90 L of OptiMEM were also incubated at room temperature for 30 min. These reagents were combined and incubated for 10 min at room temperature before addition of 800 L of OptiMEM to make the transfection medium. The culture medium was removed from the cells and replaced with transfection medium. Cells were then incubated for 3-5 h at 37°C and 5% CO 2 . The transfection medium was removed and replaced with MEM ϩ 10% FCS. Twelve to twentyfour hours later, cells expressing green fluorescence were analyzed for electrophysiological properties. 
Electrophysiological recordings
Single HEK293 cells demonstrating fluorescence were voltageclamped using the whole cell variant of the patch-clamp technique as described before . Membrane currents were filtered at 5 KHz (Ϫ3dB) using a four-pole low-pass Bessel filter digitized with a 12-bit A/D converter and stored for offline analysis using a microcomputer. Voltage paradigms were generated from a 12-bit D/A converter using pClamp software. After the whole cell configuration had been established, series resistance and cell capacitance compensation were carried out before the recording, with 90% series resistance compensation normally applied. All experiments were conducted at room temperature (22-24°C).
Solutions and drugs
The modified Hank's Balanced Salt solution (HBS) utilized for transfected cells and perfusion bath contained (in mM) 140 NaCl, 5.4 KCl, 2.5 CaCl 2 , 0.5 MgCl 2 , 10 HEPES, and 10 glucose. The internal solution contained (in mM) 140 CsCl, 1.0 MgCl 2 , 5 HEPES, 11 EGTA, and 0.5 CaCl 2 . Internal and external solutions were adjusted to a pH of 7.4 and had osmolalities of 300 and 287 mOsM, respectively. The drugs tested were freshly prepared from powder or from stocks at desired concentrations in the HBS external solution. All the chemicals and drugs including ATP were purchased from Sigma (St. Louis, MO) except for 2-methylthioATP (2-MeSATP), ␣,␤-methyleneATP ( ␣,␤-MeATP), pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS), and suramin, which were from Research Biochemicals International (Natick, MA). All the drug solutions were delivered from a U-tubing system that applied drug solution around the cell for a select period of time while the bath was continuously exchanged with a perfusion system separate from the Utubing system as described previously . The solution surrounding a cell can be exchanged within 20 to 30 ms (Murase et al. 1989) .
All the data are reported as means Ϯ SE. Student's t-test or analysis of variance (ANOVA) were applied for statistical comparison when appropriate, and differences were considered significant when P Ͻ 0.05.
R E S U L T S
Current-voltage relationship of the ATP-gated receptor channels
When HEK293 cells were individually and transiently transfected with the P2X 2 splice variants, a homomeric ATP-gated ion channel was formed as evidenced by the inward currents that were evoked at negative holding potentials in response to the application of ATP to the HEK293 cells expressing the splice variants (Fig. 1, A-C) . No ATP-induced current was elicited in nontransfected cells (data not shown). To determine the current-voltage (I-V) relationships of the ATP-gated current in cells expressing individual subunits, ATP (30 M for the P2X 2-1 , 10 M for the P2X 2-2 , and 1 mM for the P2X 2-3 ) induced current responses were recorded at various holding potentials from Ϫ100 to ϩ20 mV (Fig. 1D) . The reversal potential of the ATP-gated currents was Ϫ1.2 Ϯ 0.4 (SE) mV (n ϭ 4) for the P2X 2-1 , Ϫ0.5 Ϯ 0.3 mV (n ϭ 6) for the P2X 2-2 , and Ϫ1.5 Ϯ 0.6 mV (n ϭ 5) for the P2X 2-3 , suggesting that the P2X receptors in HEK293 cells form nonselective cation channels. The I-V relationship (Fig. 1D) for the current exhibited inward rectification. This rectification was quantified by calculating a ratio of amplitudes of the ATP-gated current at 50 mV and Ϫ50 mV (I 50 mV /I Ϫ50 mV ) as described by Evans et al. (1996) and . The rectification indices for the three subunits were similar (P2X 2-1 : 0.13 Ϯ 0.01, n ϭ 5; P2X 2-2 : 0.11 Ϯ 0.01, n ϭ 4; P2X 2-3 : 0.14 Ϯ 0.02, n ϭ 5) and suggested a strong inward rectification of three P2X 2 splice variants. This index was smaller than that of cloned P2X 1 and P2X 2 (Evans et al. 1996) but similar to the ATP-induced current recorded in Deiters' cells . a dose-dependency in all three subunits, although there were differences in the magnitude of the current response. The currents were much larger in the cells expressing the P2X 2-1 and P2X 2-2 variants than in cells expressing the P2X 2-3 variant. In addition, the concentration of ATP required to evoke a response was much higher in the cells expressing the P2X 2-3 variant compared with the other two variants (Fig. 2) . The EC 50 for ATP in cells expressing the P2X 2-1 and P2X 2-2 variants was 10 and 8 M, respectively, whereas it was 55 M for the P2X 2-3 variant. In most cells expressing the P2X 2-2 variant, at a holding potential of Ϫ60 mV, 100 M ATP induced a current amplitude that was larger than the maximum current amplitude that can be measured with the Axopatch 200A amplifier (i.e., 20 nA). Therefore the dose-response curve for ATP only extend up to 30 M for the P2X 2-2 variants (Fig. 2) .
ATP-induced dose-response relationship
Rate of desensitization of the ATP-induced response
One of the distinguishing characteristics of different P2X receptors is the rate of desensitization. The currents evoked by ATP in the cells expressing the P2X 2-1 and P2X 2-2 variants desensitized rapidly in the presence of the purinoceptor agonists whereas the P2X 2-3 variant desensitized very slowly (Fig.  3A) . The desensitization was more pronounced during prolonged application of a high concentration of ATP (30 M for the P2X 2-1 and P2X 2-2 variants; 1 mM for the P2X 2-3 variant; Fig. 3A ). Because the P2X 2-3 variant exhibited virtually no desensitization, the current waveforms could not be fit with exponential functions and no time constant was obtained. Because desensitization rate is concentration and activity dependent, the slow desensitization of the P2X 2-3 variant may be caused by the lack of agonist affinity. The current decay for the P2X 2-1 and P2X 2-2 variants was fitted well by a double exponential function. The time constant () of the current decay was 1 ϭ 3.92 Ϯ 0.6 s and 2 ϭ 15.77 Ϯ 2.99 s (n ϭ 10) for the P2X 2-1 subunit and 1 ϭ 0.99 Ϯ 0.2 s and 2 ϭ 7.56 Ϯ 0.57 s (n ϭ 10) for the P2X 2-2 subunit (Fig. 3B ). The differences in two time constants between the P2X 2-1 and P2X 2-2 variants were significant (P Ͻ 0.01). In addition, the difference in the percentage of current remaining at the end of ATP application to cells expressing the P2X 2-1 subunit (4.5 Ϯ 0.9%, n ϭ 10) and the P2X 2-2 subunit (1.7 Ϯ 0.4%, n ϭ 10) was significant (P Ͻ 0.05). Approximately 95% (P2X 2-1 ) and 98% (P2X 2-2 ) FIG. 3. Desensitization of ATP-induced current response. A: current traces recorded from HEK cells expressed individually with the P2X 2-1 , P2X 2-2 , and P2X 2-3 . The inward current was elicited by an application of 30 M ATP for the P2X 2-1 and the P2X 2-2 , and 1 mM for the P2X 2-3 for 1 min at a holding potential of Ϫ60 mV. B: scatter plots of fast-decaying time constants ( 1 ) and slow time constants ( 2 ) for the P2X 2-1 (n ϭ 10) and P2X 2-2 (n ϭ 10). Mean time constants Ϯ SE are set off to the right of the scatter.
of the current was desensitized during the 1-min period of agonist application.
Effects of purinoceptor agonists
Another distinguishing characteristic of different P2X receptors is the potency of various agonists such as 2-MeSATP and ␣,␤-MeATP (Burnstock 1990; Fredholm et al. 1997; Kennedy and Leff 1995) . Therefore these agonists were used to determine pharmacologic differences among the three P2X 2 receptor splice variants. Figure 4 shows that the three variants exhibited a similar response to 2-MeSATP and ␣,␤-MeATP except for differences in current amplitudes. Compared with ATP, 2-MeSATP exhibited strong agonist activity, whereas ␣,␤-MeATP exhibited weak agonist activity (Fig. 4, A-C) . The order of agonist potency is very similar to that observed in native Deiters' cells .
Effect of purinergic antagonists
During coapplication of ATP with the ATP receptor antagonist suramin (100 M), the currents evoked by ATP were reversibly reduced in HEK293 cells expressing P2X 2-1 , P2X 2-2 , and P2X 2-3 splice variants (Fig. 5, A-D) . Suramin reduced the ATP-induced current to a greater degree in the cells expressing the P2X 2-3 splice variants (Fig. 5, C and D) and the reduction in cells expressing the P2X 2-1 was not significant (Fig. 5D ). During coapplication of ATP with the ATP receptor antagonist PPADS (100 M), the currents evoked by ATP were significantly reduced in HEK293 cells expressing P2X 2-3 splice variants but not in cells expressing the P2X 2-1 or P2X 2-2 splice variants (Fig. 6, A-D) . Immediately after washing out the PPADS the current evoked by ATP was significantly reduced in cells expressing P2X 2-1 , P2X 2-2 , and P2X 2-3 splice variants (Fig. 6, A-D) . A similar delayed block of ATP-induced currents by PPADS was obtained previously in cells from the organ of Corti ).
D I S C U S S I O N
Results demonstrate that when P2X 2-1 , P2X 2-2 , and P2X 2-3 splice variants were individually and transiently transfected in HEK293 cells, each formed homomeric ATP-gated ion channels. The homomeric P2X 2-3 receptor differed greatly from P2X 2-1 and P2X 2-2 receptors in that the former was less sensitive to various agonists and required a higher concentration of agonist to elicit a measurable response. Even at high agonist concentrations the P2X 2-3 receptor induced less overall current than the P2X 2-1 and P2X 2-2 receptors. At the concentrations of agonists tested, the P2X 2-3 receptor exhibit little FIG. 4. Effects of purinoceptor receptor agonists on HEK293 cells expressing homomeric (A) P2X 2-1 , (B) P2X 2-2 , and (C) P2X 2-3 guinea pig ATP receptor splice variants. Shown are current traces evoked in response to the application of ATP (3 and 10 M), ␣,␤-methyleneATP ( ␣,␤-MeATP; 300 and 100 M), and 2-methylthioATP (2-MeSATP; 3 and 10 M) demonstrating that the order of potency was 2-MeSATP Ͼ ATP Ͼ ␣,␤ -MeATP for all 3 splice variants. Current traces in each row are from the same cell and the holding potential was Ϫ60 mV.
desensitization. However, because desensitization is a function of agonist concentration and induced response, the lack of desensitization may be the result of the low potency of agonists at this receptor.
The low potency of agonists suggests the P2X 2-3 receptor splice variant, if expressed in vivo as a homomeric receptor, would probably have little sensitivity for endogenous ATP. However, the homomeric P2X 2-3 receptor expressed in HEK293 may not reflect the same sensitivity as the endogenously expressed receptor. For instance, it may be that in vivo the P2X 2-3 subunit is part of a heteromeric receptor with one or both of the other variants, in which case the P2X 2-3 receptor would act as a modulator or modifier. This can be addressed in the future by studying stable transfected HEK293 cells containing all of the various combinations of the subunits. In addition, one cannot exclude the possibility that other variants or proteins not described to date are present which also have modulatory activity either alone or in combinations with the identified splice variants. Overall the obstacles for elucidating the structures that determine the response to ATP in vivo may be elusive as it has been for other agonists and their receptors. For example, striking differences have been described between natively and recombinantly expressed NMDA receptors (for review see Sucher et al. 1996) .
Presumably, the P2X 2-3 splice variant found in the guinea pig cannot be found in the rat. The molecular mechanism which produces this variant in the guinea pig is the inclusion of an intron which codes for an additional nine amino acids (i.e., intron VIII; Parker et al. 1998 ). In the rat this intron contains a stop codon. Therefore if this sequence were included in the rat mRNA, presumably it would result in a truncated protein lacking the second transmembrane spanning region of the receptor and would therefore be nonfunctional. This raises the question of why the guinea pig makes this splice variant and FIG. 5. Effects of the purinoceptor receptor antagonist, suramin (Sur; 100 M) on the ATP induced current in HEK293 cells expressing homomeric (A) P2X 2-1 (10 M ATP), (B) P2X 2-2 (10 M ATP), and (C) P2X 2-3 (300 M ATP) guinea pig ATP receptor splice variants. Shown are the induced currents in response to the application of ATP-alone (ATP), of an ATP with suramin combination (Sur), and of ATP alone after washing the bath (Wash). D: summary of the effect of suramin on the ATP-induced current response. The first ATP alone application was used to derive the current reduction (%). Each bar represents the mean Ϯ SE for the indicated number of cells. Asterisks indicate a significant difference (**P Ͻ 0.01) from a presuramin ATP-induced control current. the rat does not and what effect this variant has on the function of the cochlea and other tissue where it may be expressed (Parker et al.1999) . To date there is only preliminary data on this question. Chen et al. (1997) failed to obtain responses to application of ATP in a majority of rat OHCs, yet obtained large responses in guinea pig OHCs. Because the guinea pig OHC response to ATP is a nondesensitizing response Housley et al. 1992; Nakagawa et al. 1990 ), the P2X 2-3 splice variant failed to demonstrate desensitization and the P2X 2-3 splice variant is absent from the rat; this variant is a candidate for being the receptor present in guinea pig OHCs and the one being absent from rat OHCs.
It appears that the recombinant P2X 2-1 and P2X 2-2 receptors fairly accurately reflect the activity of the receptors expressed in Deiters' cells and possibly other supporting cells such as pillar cells in both species . The nucleotide sequences of these guinea pig receptors are very similar to the P2X 2-1 and P2X 2-2 receptor sequences found in the rat (Parker et al. 1998 ) and so the responses should be similar in both species. The homomeric P2X 2-1 and P2X 2-2 receptors both desensitize rapidly and exhibit similar dose response curves to various agonists including ATP. Therefore they respond similarly to the receptors on Deiters' cells in both the rat and the guinea pig Chen et al. 1997) . Brandle et al. (1997) and Simon et al. (1997) found the rat P2X 2-2 receptor had a faster desensitization time constant than the P2X 2-1 receptor when the subunits were expressed in Xenopus oocytes. A similar relationship was observed between the guinea pig P2X 2-1 and P2X 2-2 receptors in the present study; however, the guinea pig time constants were approximately twice the rates of those found in the rat. This difference between rat and guinea pig may be because Brandle et al. FIG. 6. Effects of the purinoceptor receptor antagonist, pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS; 100 M) on the ATP induced current in HEK293 cells expressing homomeric (A) P2X 2-1 (10 M ATP), (B) P2X 2-2 (10 M ATP), and (C) P2X 2-3 (300 M ATP) guinea pig ATP receptor splice variants. Shown are the induced currents in response to the application of ATP-alone (ATP), of an ATP with PPADS combination (PPADS) and of ATP alone after washing the bath (Wash). D: summary of the effect of PPADS on the ATP-induced current response demonstrating the greater reduction in the evoked current after the application and washout of the PPADS (Wash) than obtained with coapplication of ATP with PPADS (PPADS). First ATP alone application was used to derive the current reduction (%). Each bar represents the mean Ϯ SE for the indicated number of cells. Asterisk indicates a significant difference from a pre-PPADs ATP-induced control current (**P Ͻ 0.01).
(1997) and Simon et al. (1997) made their measurement on receptors expressed in Xenopus oocytes which might have different posttranslational modification steps than the HEK293 cells used in this study. However, similar slower rate constants for rat P2X 2-1 and P2X 2-2 using Ca 2ϩ flux in HEK293 cells and neurons was reported by Koshimizu et al. (1998) In summary, P2X 2-1 , P2X 2-2 , and P2X 2-3 splice variants formed homomeric ATP-gated ion channels when they were individually and transiently transfected into HEK293 cells. These ion channels exhibited differences in the rate of desensitization, magnitude, and pharmacology of the ATP-induced current responses among three splice variants. The distinct properties of these P2X 2 receptor splice variants may contribute to the differences in the response to ATP observed in native cochlear cells.
